Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 114 participants.
Also called NCT06487949
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 114 participants
- Registry
-
NCT06487949
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Iran
- Registry status
- Completed
Technical summary
Registry record NCT06487949. Randomized; quadruple masking; primary purpose treatment. Start 2022-12-01 (actual); primary completion 2023-10-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy
- Condition
- Hypertension
- Intervention (Drug)
- valsartan-amlodipine 80/5 mg FDC
- Intervention (Drug)
- valsartan 80 mg and amlodipine 5 mg as free combination
- Lead sponsor
- Shiraz University of Medical Sciences
Record details
- Record id
cardio:ct-nct06487949- Content hash
a80f1af7777e28f8ed7c1d8602f80bc51adb6f564a6252e7d0c437c9f022db73